Questions to Ask your Doctor: If You’re Considering Undergoing Prostate Cancer Surgery
A surgical approach to treating prostate cancer entails removing all of the prostate. Typically, men with early-stage disease or cancer that’s confined to the prostate will undergo radical prostatectomy- removal of the entire prostate gland, plus some surrounding tissue. Other surgical procedures may be performed on men with advanced or recurrent. Read More
08/09/2016
Prostate Cancer Dream Challenge
The Prostate Cancer DREAM Challenge launched on March 16th and will be running through July 2015; this project is a collaboration with Project Data Sphere, LLC, the DREAM Project, the Prostate Cancer Foundation, and Sage Bionetworks. The objectives of the Challenge are to: address clinically relevant research questions regarding patients. Read More
08/09/2016
PCF Celebrates the Life and Legacy of our Dear Friend and Honorary Board Member Jerry Weintraub
The Prostate Cancer Foundation wishes to celebrate the life and legacy of our dear friend and honorary board member Jerry Weintraub, who passed away on July 6, 2015. His larger than life persona was always evident in his considerable accomplishments as a producer, manager and leader in the arts and. Read More
Follow Up Care
After surgery or radiation for localized prostate cancer, your PSA will likely fall. After surgery, your PSA should be undetectable (<0.1 ng/dl) after about 30 days and should remain at this level. A rising PSA can be a sign of early recurrence, and given that radiation is more effective if. Read More
Questions to Ask
Below is a list of questions to ask your doctor when you’re diagnosed with early-stage disease. What is my risk of recurrence after surgery or radiation based on my Gleason score, PSA, rate of PSA rise, and stage? What is my risk of progression over time without therapy? Do I. Read More
Issues to Consider
Read a list of 15 things to consider if you've been diagnosed with prostate cancer — from PSA and Gleason scores to treatment decisions and lifestyle recommendations for prostate health. Read More
Young Investigator Award-Class of 2015
The PCF Young Investigator Award-Class of 2015 recipients are: 2015 David H. Koch–PCF Young Investigator Wassim Abida, MD, PhD Memorial Sloan Kettering Cancer Center Mentors: Howard Scher, MD; Charles Sawyers, MD Proposal Title: Investigating Treatment Selection and Resistance Using Prostate Cancer Genomics Description Genomic profiling of primary and metastatic treatment-resistant prostate. Read More
Challenge Awards-Class of 2015
2015-2017 Movember Foundation-PCF Challenge Award ($1 Million) Project Title: Targeting the MLL Complex for the Development of New Therapeutics for CRPC Principal Investigator: Shaomeng Wang, PhD (University of Michigan) & Arul Chinnaiyan, MD, PhD (University of Michigan) Co-investigators: Rohit Malik, PhD (University of Michigan), Angelo Anguilar, PhD (University of. Read More
Young Investigator Award-Class of 2014
The PCF Young Investigator Award-Class of 2014 recipients are: 2014 Clay and Lynn Hamlin-PCF Young Investigator W. Nathaniel Brennen, PhD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Mentors: John Isaacs, PhD, Charles Drake, MD, PhD Proposal Title: T cells Engineered to Selectively Deliver a PSA-activated Protoxin to Sites. Read More
Challenge Awards-Class of 2014
MOVEMBER-PCF CHALLENGE AWARDS Movember-PCF Challenge Award ($1 Million) Project Title: Periprostatic adipose inflammation: A targetable mediator of prostate cancer progression Principal Investigator: Andrew Dannenberg, MD (Weill Cornell Medical College) Co-investigators: Kotha Subbaramaiah, PhD (Weill Cornell Medical College), Xi Kathy Zhou, PhD (Weill Cornell Medical College), Howard Scher, MD (Memorial Sloan. Read More